The Third Xiangya Hospital of Central South University
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China11 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation and Bolus Maintenance in Adults | Neuromuscular Blockade | Recruiting | Phase 3 | 2026-09-22 | NCT07746726 | |
| A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection | Advanced Lung Cancer | Recruiting | Phase 1 / Phase 2 | 2026-09-08 | NCT07367529 | |
| Clinical Trial of TQB3126 for Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Breast Cancer Subjects | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-07-13 | NCT07697443 | |
| Indomethacin vs Diclofenac for Preventing PEP | Digestive System Diseases, pancreas disorder, pancreatitis | Recruiting | Not applicable | 2026-06-15 | NCT07071441 | |
| Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy（RECAST-MT） | Acute Ischemic Stroke, Anterior Circulation Brain Infarction, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain infarction, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic disease, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 3 | 2025-12-10 | NCT06559241 | |
| Rectal NSAIDs With/Without PD Stent for PEP Prevention | Non-steroid Anti-inflammatory Drugs; Pancreatic Duct Stent Placement; Post-ERCP Acute Pancreatitis | Recruiting | Not applicable | 2025-12-03 | NCT07117318 | |
| Value of IUS in Predicting Vedolizumab Efficacy and Assessing Transmural Healing in Early Crohn's Disease: A Multicenter, Prospective Study | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Recruiting | Not stated | 2025-07-30 | NCT07093294 | |
| IUS Predicts Guselkumab Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study | Crohn's Disease; Guselkumab; Intestinal Ultrasound; Predictor | Recruiting | Not stated | 2025-06-24 | NCT07034664 | |
| Validation of an AI-Assisted Mediastinal EUS System for Training Improvement: a Prospective, Multi-Center, Randomized Trial | Mediastinal Diseases, Thoracic Diseases, respiratory system disorder | Recruiting | Not applicable | 2025-01-23 | NCT06790108 | |
| Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition. | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, end stage renal failure, kidney disorder, kidney failure, nutritional deficiency disease, nutritional disorder, urinary system disorder | Recruiting | Phase 4 | 2024-12-30 | NCT06597201 | |
| Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders. | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cryptogenic Ischemic Stroke, atrial septal defect, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, congenital heart disease, heart disorder, heart septal defect, ischemic stroke, nervous system disorder, patent foramen ovale, stroke disorder, vascular disorder | Recruiting | Not applicable | 2023-09-01 | NCT05774288 |